Logo
Menu
Overview

Summary

Affiliates

Contact details

Officers35

Finance1

Documents100

Additional data

Identification numbers1

Related companies6

FAQ

Find out more about how much SYNEXUS CLINICAL RESEARCH LIMITED
earned last year and more by getting full access

Last updated: Jun 01, 2024

SYNEXUS CLINICAL RESEARCH LIMITED

Active

is not in process of liquidation on Jun 1, 2024

Private limited company

United Kingdom 27 Sep 2005 (19 years ago)

Share viaTwitterFacebookLinkedin

Summary

NameSYNEXUS CLINICAL RESEARCH LIMITED
Status
  • ActiveActive
JurisdictionActiveUnited Kingdom
Company numberCode05575991
LEI Code
  • 213800PZ2QNGOJPYZR19
Incorporation Date27 Sep 2005 (19 years ago) / 773 companies with the same date
Legal formPrivate limited company

Affiliates

Local connections
SYNEX**********

ActiveUnited Kingdom

Contact details

Legal addressENGLAND, CAMBRIDGE, 12B GRANTA PARK, GREAT ABINGTON, CB21 6GQ

Officers

corporate

IndividualUnited Kingdom

SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LIMITED

Person with significant control


Appointed on31 Aug 2016

corporate

IndividualUnited Kingdom

SYNEXUS CLINICAL RESEARCH ACQUISITIONS LIMITED

Person with significant control


Appointed on06 Apr 2016

Resigned on31 Aug 2016

individual

IndividualUnited Kingdom

Harris, Richard Stuart

Director


Appointed on30 Jun 2021

Resigned on29 Mar 2023

Country of residenceEngland

individual

IndividualUnited Kingdom

James, Julia Mary

Director


Appointed on31 May 2016

Country of residenceUnited Kingdom

individual

IndividualUnited Kingdom

Mccluskey, Paul

Secretary


Appointed on28 Jun 2007

Resigned on30 Jun 2011

individual

IndividualUnited Kingdom

Halliwells Secretaries Limited

Nominee Secretary


Appointed on04 Sep 2006

Resigned on28 Jun 2007

Get ahead with complete company information - register now.

Join the 50,000+ businesses already using B2BHint.

Sign up

Financial reports

YearTurnoverNet profitFixed assetsOther
2021110,700,000 GBP
(~$152,243,221)
-200,000 GBP
(~-$275,056)
11,058,000 GBP
(~$15,207,819)
View full report

Find out all the information about the company

Get full access to the data

View more data

Documents

DateNameTypeDocument
05 Jul 2022Change person director company with change dateCH01View
05 Jul 2022Confirmation statement with no updatesCS01View
06 Jan 2022Move registers to sail company with new addressAD03View

Find out all the information about the company

Get full access to the data

Additional data

Accounts
  • First accounts made up to31 Dec 2023
    due by 30 Sep 2024
  • Last accounts made up to31 Dec 2022
  • CategoryFULL
Confirmation statement
  • Next statement date23 Jun 2024
    due by 07 Jul 2024
  • Last statement dated23 Jun 2023
Returns
  • Next returns datedue by 12 Oct 2016
  • Last returns dated14 Sep 2015
Mortgages
  • Charges17
  • Satisfied17

Identification numbers

Data from the LEI register
  • 213800PZ2QNGOJPYZR19
  • Legal nameSYNEXUS CLINICAL RESEARCH LIMITED
  • Registration date30 Jul 2015
  • StatusActiveExpired
  • IssuerActiveLONDON STOCK EXCHANGE LEI LIMITED
  • Last updated30 Jul 2015
  • Next renewal30 Jul 2016

Related companies by address

Related companies by officers

Frequently asked questions

Where is SYNEXUS CLINICAL RESEARCH LIMITED's headquarters?

SYNEXUS CLINICAL RESEARCH LIMITED's headquarters is located at ENGLAND, CAMBRIDGE, 12B GRANTA PARK, GREAT ABINGTON, CB21 6GQ

What is SYNEXUS CLINICAL RESEARCH LIMITED's industry?

SYNEXUS CLINICAL RESEARCH LIMITED is in the industry of Other professional, scientific and technical activities n.e.c.

What year was SYNEXUS CLINICAL RESEARCH LIMITED started?

SYNEXUS CLINICAL RESEARCH LIMITED was started in 2005

What is the LEI number of SYNEXUS CLINICAL RESEARCH LIMITED?

SYNEXUS CLINICAL RESEARCH LIMITED LEI number is 213800PZ2QNGOJPYZR19

How much does SYNEXUS CLINICAL RESEARCH LIMITED generate in sales?

SYNEXUS CLINICAL RESEARCH LIMITED's sales is $152,243,221

How much profit does SYNEXUS CLINICAL RESEARCH LIMITED make?

SYNEXUS CLINICAL RESEARCH LIMITED's profit is -$275,056

Sources: Companies House